Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. Cash Return on Invested Capital (CROIC)
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Return on Invested Capital (CROIC) | (186.1%) | (135.5%) | (230.5%) | 1,265.2% | 327.9% | (515.6%) | 93.7% | 52.9% | 213.4% | (479.9%) | (569.1%) | (613.4%) | (724.5%) | (359.4%) | (280.7%) | (83.7%) | (88.7%) | (78.4%) | (54.4%) | 2.7% |
Alnylam Pharmaceuticals, Inc. (ALNY) Cash Return on Invested Capital (CROIC) comparison analysis
ALNY key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Alnylam Pharmaceuticals, Inc.'s Cash Return on Invested Capital (CROIC)?
As of today, Microsoft Corp's last 12-month Cash Return on Invested Capital (CROIC) is 1.5%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Cash Return on Invested Capital (CROIC) for Alnylam Pharmaceuticals, Inc. have been (41.2%) over the past three years, and (54.6%) over the past five years.
2) Is Alnylam Pharmaceuticals, Inc.'s Cash Return on Invested Capital (CROIC) Good?
As of today, Alnylam Pharmaceuticals, Inc.'s Cash Return on Invested Capital (CROIC) is 1.5%, which is higher than industry median of (98.1%). It indicates that Alnylam Pharmaceuticals, Inc.'s Cash Return on Invested Capital (CROIC) is Good.